Vladimir Putin was seen on video seemingly struggling to control the movements of his left foot during a meeting with North Korea's Kim Jong Un in Russia Wednesday, fueling speculation about the state of his health.
A Bayer cell therapy for Parkinson’s disease has met primary and secondary goals of its first test in humans, and the pharmaceutical giant is now planning for a larger Phase 2 clinical trial expected to begin enrollment in the first half of next year.
With the help of artificial intelligence, Parkinson's disease can be predicted via eye scans with an average seven years of warning, researchers from a London hospital boast.
Healthcare technology company Koneska is extending its contribution to critical neuroscience research by collaborating with an academic partnership program.